Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2024-09-25

Clinical Trial Update: 650nm Low-level Red-light for Myopia Control and Prevention in Children [NA]

View source ↗

Summary

Clinical trial evaluating 650nm low-level red-light therapy for myopia control in children; status shows ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 650nm Low-level Red-light therapy (low-level red-light therapy)

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: Myopia | NA | Status: ACTIVE_NOT_RECRUITING